What characterizes episodes of atrial fibrillation requiring cardioversion? Experience from patients with an implantable atrial cardioverter

American Heart Journal

Volumn 145, Issue 4, 2003, Pages 670-675

  Frykman, Viveka ^a   Ayers, Gregory M ^b   Darpö, Börje ^a   Rosenqvist, Mårten ^c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b BOSTON SCIENTIFIC CORPORATION   (United States)

^c STOCKHOLM SÖDER HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVERSION; CONTROLLED STUDY; DEFIBRILLATOR; ELECTROCARDIOGRAM; ELECTROGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HEART RATE; HEART VENTRICLE CONTRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0344406961     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2003.93     Document Type: Article

References (27)

1. Kannel WB, Abbot RD, Savage DD, et al. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med 1982;306:1018-22.
2. Lip GY, Tean KN, Dunn FG. Treatment of atrial fibrillation in a district general hospital. Br Heart J 1994;71:92-5.
3. Daoud EG, Weiss R, Bahu M, et al. Effect of an irregular ventricular rhythm on cardiac output. Am J Cardiol 1996;78:1433-6.
4. Clark DM, Plumb V J, Epstein AE, et al. Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. J Am Coll Cardiol 1997;30:1039-45.
5. Naito M, David D, Michelson EL, et al. The hemodynamic consequences of cardiac arrhythmias: evaluation of the relative roles of abnormal atrioventricular sequencing, irregularity of ventricular rhythm and atrial fibrillation in a canine model. Am Heart J 1983;106:284-91.
6. Schneider F, Martin DT, Schick EC, et al. Interval-dependent changes in left ventricular contractile state in lone atrial fibrillation and in atrial fibrillation associated with coronary artery disease. Am J Cardiol 1997;80:586-90.
7. Packer DL, Bardy GH, Worley SJ, et al. Tachycardia-induced cardiomyopathy: a reversible form of left ventricular dysfunction. Am J Cardiol 1986;57:563-70.
8. Grogan M, Smith HC, Gersh BJ, et al. Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. Am J Cardiol 1992;69:1570-3.
9. Peters KG, Kienzle MG. Severe cardiomyopathy due to chronic rapidly conducted atrial fibrillation: complete recovery after restoration of sinus rhythm. Am J Med 1988;85:242-4.
10. Karlöf I. Haemodynamic effect of atrial triggered versus fixed rate pacing at rest and during exercise in complete heart block. Acta Med Scand 1975;197:195-206.
11. Ausubel K, Steingart RM, Shimshi M, et al. Maintenance of exercise stroke volume during ventricular versus atrial synchronous pacing: role of contractilily. Circulation 1985;72:1037-43.
12. Page RL, Wilkinson WE, Clair WK, et al. Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation 1994;89:224-7.
13. Wellens HJ, Lau CP, Luderitz B, et al. Atrioverter: an implantable device for the treatment of atrial fibrillation. Circulation 1998;98:1651-6.
14. Timmermans C, Levy S, Ayers GM, et al. Spontaneous episodes of atrial fibrillation after implantation of the Metrix Atrioverter: observations on treated and nontreated episodes. Metrix Investigators. J Am Coll Cardiol 2000;35:1428-33.
15. Tse HF, Lau CP, Sra JS, et al. Atrial fibrillation detection and R-wave synchronization by Metrix implantable atrial defibrillator: implication for long-term efficacy and safely. The Metrix Investigators. Circulation 1999;99:1446-51.
16. Sra JS, Maglio C, Dhala A, et al. Feasibilily of atrial fibrillation detection and use of a preceding synchronization interval as a criterion for shock delivery in humans with atrial fibrillation. J Am Coll Cardiol 1996;28:1532-8.
17. Lok NS, Lau CP, Tse HF, et al. Clinical shock tolerabilily and effect of different right atrial electrode locations on efficacy of low energy human transvenous atrial defibrillation using an implantable lead system. J Am Coll Cardiol 1997;30:1324-30.
18. Juul-Moller S, Edvardsson N, Rehnquist-Ahlberg N. Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation. Circulation 1990;82:1932-9.
19. Sharif MN, Wyse DG. Atrial fibrillation: overview of therapeutic trials. Can J Cardiol 1998;14:1241-54.
20. Rasch D, Tiku ML, Sumpf D. Elsevier's dictionary of biometry. Amsterdam-London-New York-Tokyo: Elsevier; 1994. p. 621.
21. Bergfeldt L, Vallin H, Rosenqvist M, et al. Sinus node recovery time, assessment revisited: role of pharmacologic blockade of the autonomic nervous system. J Cardiovasc Electrophysiol 1996;7:95-101.
22. Hayano J, Yamasaki F, Sakati S, et al. Spectral characteristics of ventricular response to atrial fibrillation. Am J Physiol 1997;273:H2811-6.
23. Yamada A, Hayano J, Sakata S, et al. Reduced ventricular response irregularily is associated with increased mortalily in patients with chronic atrial fibrillation. Circulation 2000;102:300-10.
24. Frykman V, Frick M, Jensen-Urstad M, et al. Asymptomatic versus asymptomatic persistent atrial fibrillation: clinical and noninvasive characteristics. J Intern Med 2001;5:390-7.
25. Koskinen P, Kupari M, Leinonen H, et al. Alcohol and new onset atrial fibrillation: a case-control study of a current series. Br Heart J 1987;57:468-73.
26. Koskinen P, Kupari M, Leinonen H. Role of alcohol in recurrences of atrial fibrillation in persons less than 65 years of age. Am J Cardiol 1990;66:954-9.
27. Brignole M, Gianfranchi L, Menozzi C, et al. Influence of atrioventricular junction radiofrequency ablation in patients with chronic atrial fibrillation and flutter on quality of life and cardiac performance. Am J Cardiol 1994;74:242-6.